Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo [Corrigendum]
Authors Xiang D, Zheng Y, Duan W, Li X, Yin J, Shigdar S, O’Conner ML, Marappan M, Zhao X, Miao Y, Xiang B, Zheng C
Received 12 November 2013
Accepted for publication 12 November 2013
Published 5 December 2013 Volume 2013:8(1) Pages 4703—4704
Xiang DX, Zheng Y, Duan W, et al. Int J Nanomedicine. 2013;8:4103–4114.
On page 4103, the author affiliations were incorrectly listed. The correct affiliations are listed below.
Michael Liam O’Connor2
1Department of Biology, Medical College, Dalian University, Liaoning, People’s Republic of China; 2School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia; 3Department of Pharmacology, Osaka University, Osaka, Japan; 4Department of Gynaecology and Obstetrics, Qingdao Central Hospital, Shandong, People’s Republic of China; 5Department of Oral Medicine and Medical Research Center, Medical College, Dalian University, Liaoning, People’s Republic of China
View original paper by Xiang et al.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]